Skip to main content
رجوع
Watch Compare

BIOREGENX, INC.

جودة البيانات: 100%
BRGX
OTC Technology IT Services
KWD 0.01
KWD 0.00 (0.00%)
6 months return
—
Momentum
Neutral
Net margin
-980.96%

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)10420.64%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
N/A
ROICN/A
Net Margin-980.96%
Op. Margin-965.35%

الأمان

Debt / Equity
N/A
Current Ratio0.07
Interest Coverage-116.53

التقييم

PE (TTM)
-0.60
أقل من متوسط القطاع (-0.16)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Negative free cash flow of -48,025.0
Capital efficient — spends only 0.31% of revenue on capex

Price History

الاتجاهات المالية

السعر المستهدف للمحللين

لا تتوفر تغطية محللين

Growth

Rev 5Y: N/A · Earnings 1Y: N/A
Revenue Growth (1Y) 10420.64% Revenue Growth (3Y) 645.03%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A

Profitability

ROE: N/A · Net Margin: -980.96%
Revenue (TTM) 1.93 M Net Income (TTM) -18.93 M
ROE N/A ROA -1632.76%
Gross Margin 78.14% Operating Margin -965.35%
Net Margin -980.96% Free Cash Flow (TTM) -48,025.0
ROIC N/A FCF Growth (3Y) N/A

Safety

D/E: N/A · Current: 0.07
Debt / Equity N/A Current Ratio 0.07
Interest Coverage -116.53 Asset Turnover 1.66
Working Capital -3.66 M Tangible Book Value -4.37 M

Dividends

Yield: N/A · Payout: N/A
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A

Valuation

P/E: -0.60 · EV/EBITDA: N/A
P/E Ratio -0.60 Forward P/E N/A
P/B Ratio N/A P/S Ratio 5.93
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -0.42%
Market Cap 11.44 M Enterprise Value 11.44 M

Per Share

EPS: -0.01 · FCF/Share: 0.00
EPS (Diluted TTM) -0.01 Revenue / Share 0.00
FCF / Share 0.00 OCF / Share 0.00
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A

Efficiency

FCF Conv: 0.25% · CapEx/Rev: 0.31%
CapEx / Revenue 0.31% FCF Conversion 0.25%
SBC-Adj. FCF -1.54 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022
Revenue 2.34 M 22,243.0 42,159.0
Net Income -23.05 M -571,171.0 -78,308.0
EPS (Diluted) -0.02 0.00 0.00
Gross Profit 1.66 M — 42,159.0
Operating Income -22.76 M -109,663.0 -78,308.0
EBITDA — — —
R&D Expenses 0.0 — —
SG&A Expenses 5.85 M — —
D&A 2.22 M — —
Interest Expense 6,638.0 8,276.0 —
Income Tax — 0.0 0.0

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022
Total Assets 508,535.0 31,640.0 59,149.0
Total Liabilities 3.89 M 253,612.0 260,691.0
Shareholders' Equity -3.38 M -221,972.0 -201,542.0
Total Debt 1.14 M 200,000.0 200,000.0
Cash & Equivalents 58,404.0 — —
Current Assets 307,796.0 0.0 676.0
Current Liabilities 3.63 M 253,612.0 64,880.0

مقارنة الأقران

مقابل وسيط قطاع Technology (1234 نظير)
المقياس السهم وسيط القطاع
P/E -0.6 -0.2
P/B — 3.0
ROE % — 1.5
Net Margin % -981.0 -0.6
Rev Growth 5Y % — 7.4
D/E — 0.4